Medical
UK Patients Gain Faster Access to Innovative Medicines via ILAP
UK patients are set to benefit from faster access to transformative new medicines thanks to the revamped Innovative Licensing and...
Read moreDetailsUKHSA Updates Antibiotic ‘Access’ List for Optimal Use
UK Health Security Agency (UKHSA) has updated the antibiotic 'Access' list, a crucial tool for guiding healthcare professionals in prescribing...
Read moreDetailsUK Authorities Thwart Illegal Medicine Trade
UK authorities have successfully thwarted the illegal trade in medicines, denying criminals over £7.5 million in profits last year. This...
Read moreDetailsAI Sensors Enhance Independent Living
As part of the UK government's efforts to enhance public services, AI sensors integrated into household appliances like fridges and...
Read moreDetailsThe Drug Garadacimab Approved for Angioedema Prevention
On January 24, 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) approved garadacimab, marketed as Andembry, for preventing angioedema...
Read moreDetailsIBCA Publishes Infected Blood Compensation Figures
The Infected Blood Compensation Authority (IBCA) has initiated the publication of detailed figures regarding compensation for victims of the infected...
Read moreDetailsUK Commits £5.5M to Combat Mpox Outbreaks
The UK has committed £5.5 million to support vital research projects aimed at tackling the ongoing mpox outbreaks in the...
Read moreDetailsUK Health Secretary Outlines Winter Strategies
Health and Social Care Secretary outlines critical winter strategies and long-term reforms for the UK's health and social care system....
Read moreDetailsMHRA Introduces Stricter Post-Market Surveillance Regulations
MHRA Introduces Stricter Post-Market Surveillance Requirements for Medical Devices The Medicines and Healthcare products Regulatory Agency (MHRA) has published draft...
Read moreDetailsUK Announces £126 Million Funding Boost for Early Years Support
meta_description Y=early years support funding
Read moreDetails